Sequential and contingent prenatal screening for Down syndrome

Prenatal Diagnosis

Volumn 26, Issue 9, 2006, Pages 769-777

  Wald, Nicholas J ^a   Rudnicka, Alicja R ^a   Bestwick, Jonathan P ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Contingent screening; Detection rates; Down syndrome; False positive rate; Integrated screening; Sequential screenings

Indexed keywords

ALPHA FETOPROTEIN;

ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DOWN SYNDROME; FALSE POSITIVE RESULT; FEMALE; FIRST TRIMESTER PREGNANCY; HIGH RISK PREGNANCY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MONTE CARLO METHOD; NEURAL TUBE DEFECT; PRENATAL SCREENING; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; ULTRASOUND;

COST-BENEFIT ANALYSIS; DOWN SYNDROME; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MASS SCREENING; MATERNAL AGE; MONTE CARLO METHOD; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PRENATAL DIAGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

EID: 33749470608     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.1498     Document Type: Article

References (20)

1. Benn P, Wright D, Cuckle H. 2005. Practical strategies in contingent sequential screening for Down syndrome. Prenat Diagn 25: 645-652.
2. Cuckle H. 2001. Integrating antenatal Down syndrome screening. Curr Opin Obstet Gynecol 13: 175-181.
3. Gosden C, Tabor A, Leck I, Grant A, Alfirevic Z, Wald N. 2000. Amniocentesis and chorionic villus sampling. In Antenatal and Neonatal Screening (2nd edn), Wald N, Leck I (eds). Oxford University Press: Oxford.
4. Knight GJ, Palomaki GE, Neveux LM, et al. 2005. Integrated serum screening for Down syndrome in primary obstetric practice. Prenat Diagn 25: 1162-1167.
5. Lawson HW, Frye A, Atrash HK, Smith JC, Shulman HB, Ramick M. 1994. Obstetrics: Abortion mortality, United States, 1972 through 1987. Am J Obstet Gynecol 171: 1365-1372.
6. Morris JK, Wald NJ, Watt HC. 1999. Fetal loss in Down syndrome pregnancies. Prenat Diagn 19: 142-145.
7. Morris JK, Mutton DE, Alberman E. 2002. Revised estimates of the maternal age specific live birth prevalence of Down's syndrome. J Med Screen 9: 2-6.
8. Morris J, Mutton D, Alberman E. 2005. Corrections to maternal age-specific live birth prevalence of Down's syndrome. J Med Screen 12: 202.
9. National Institute for Clinical Excellence. 2001. Why Mothers Die 1997-1999. The Fifth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. RCOG Press: London.
10. Office for National Statistics. 1998. Birth Statistics. England and Wales; 1996; 1997;1998 (FMI, Nos 25-27). The Stationery Office: London.
11. Palomaki GE, Kloza EM, Haddow JE, Williams J, Knight GJ. 2005. Patient and health professional acceptance of integrated serum screening for Down syndrome. Semin Perinatol 29: 247-251.
12. Summers AM, Huang T, Meier C, Farrell SA. 2005. Contingent screening for Down syndrome. Prenat Diagn 25: 960-969.
13. Wald N, Hackshaw A. 2000. Tests using multiple makers. In Antental and Neonatal Screening (2nd edn), Wald NJ, Leck I (eds). Oxford University Press: Oxford; 23-57.
14. Wald NJ, Rudnicka A. Antenatal screening for Down's syndrome using the integrated test. In Prenatal Medicine, Van Vugt JMG, Shulman LP (eds), (In press).
15. Wald NJ, Watt HC, Hackshaw AK. 1999. Integrated screening for Down's syndrome based on tests performed during the first and second trimesters. N Engl J Med 341: 461-467.
16. Wald NJ, Rodeck C, Hackshaw AK, Rudnicka A. 2004a. SURUSS in perspective. Br J Obstet Gynaecol 111: 521-531.
17. Wald N, Rodeck C, Rudnicka A, Hackshaw A. 2004b. Nuchal translucency and gestational age. Prenat Diagn 24: 150-153.
18. Wald NJ, Rodeck C, Hackshaw AK, Walters J, Chitty L, Mackinson AM. 2003. First and Second trimester Antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS). J Med Screen 10: 56-104.
19. Wald NJ, Cuckle HS, Densem JW, et al. 1988. Maternal serum screening for Down's syndrome in early pregnancy. BMJ 297: 883-887.
20. Wright D, Bradbury I, Benn P, Cuckle H, Ritchie K. 2004. Contingent screening for Down syndrome is an efficient alternative to non-disclosure sequential screening. Prenat Diagn 24: 762-766.